Skip to content
TrialScanner

NCT05120830

NTLA-2002 in Adults With Hereditary Angioedema (HAE)

Phase 1/Phase 2Active, not recruitingNTLALead

Registry record

Lead sponsor
Intellia Therapeutics
Conditions
Hereditary Angioedema
Primary completion
Apr 4, 2024Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT05120830 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT05120830: NTLA-2002 in Adults With... | TrialScanner